1. Home
  2. ONMD vs CLRB Comparison

ONMD vs CLRB Comparison

Compare ONMD & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneMedNet Corp

ONMD

OneMedNet Corp

BUY

Current Price

$4.71

Market Cap

25.0M

Sector

N/A

ML Signal

BUY

Logo Cellectar Biosciences Inc.

CLRB

Cellectar Biosciences Inc.

BUY

Current Price

$1.22

Market Cap

24.5M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
ONMD
CLRB
Founded
2006
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.0M
24.5M
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
ONMD
CLRB
Price
$4.71
$1.22
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $11.50
AVG Volume (30 Days)
54.3K
★ 148.5K
Earning Date
11-13-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 83.33
N/A
EPS
★ N/A
N/A
Revenue
★ $1,359,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 111.35
N/A
52 Week Low
$0.63
$1.12
52 Week High
$123.00
$4.70

Technical Indicators

Market Signals
Indicator
ONMD
CLRB
Relative Strength Index (RSI) 30.48 25.83
Support Level $3.61 N/A
Resistance Level $35.00 $3.03
Average True Range (ATR) 0.35 0.15
MACD 1.00 0.01
Stochastic Oscillator 72.34 11.49

Price Performance

Historical Comparison
ONMD
CLRB

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. The products under development include Iopofosine, CLR 121125 ,CLR 121225 and others. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

Share on Social Networks: